share_log

騰盛博藥-B：授出購股權及受限制股份單位

BRII-B: GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS

香港交易所 ·  Mar 28 10:15
Summary by Moomoo AI
腾盛博药-B（Brii Biosciences Limited）於2024年3月28日根據2023年購股權計劃及股份獎勵計劃，向55名購股權承授人授出合共5,752,500份購股權，以及向18名受限制股份單位承授人授出合共821,500份受限制股份單位。該行動旨在調動員工積極性，並將公司利益與員工福利保持一致。購股權的行使價為每股0.964港元，而受限制股份單位的授出則無需支付購買價。購股權及受限制股份單位的歸屬期分別為四年，並將按年度分批歸屬。此舉反映了公司對員工過往貢獻的認可及對其未來貢獻的期待，同時也是公司薪酬政策的一部分，旨在吸引及留住關鍵人才，並鼓勵他們為公司及其股東的整體利益提高公司及其股份的價值。
腾盛博药-B（Brii Biosciences Limited）於2024年3月28日根據2023年購股權計劃及股份獎勵計劃，向55名購股權承授人授出合共5,752,500份購股權，以及向18名受限制股份單位承授人授出合共821,500份受限制股份單位。該行動旨在調動員工積極性，並將公司利益與員工福利保持一致。購股權的行使價為每股0.964港元，而受限制股份單位的授出則無需支付購買價。購股權及受限制股份單位的歸屬期分別為四年，並將按年度分批歸屬。此舉反映了公司對員工過往貢獻的認可及對其未來貢獻的期待，同時也是公司薪酬政策的一部分，旨在吸引及留住關鍵人才，並鼓勵他們為公司及其股東的整體利益提高公司及其股份的價值。
On 28 March 2024, Brii Biosciences Limited granted a total of 5,752,500 shares to 55 licensees under the 2023 Share Option Plan and Share Award Scheme and granted a total of 821,500 restricted shares to 18 restricted share units. The action aims to mobilize employee positivity and align the interests of the company with the welfare of employees. The exercise price of the share option is HK$0.964 per share, and the issuance of restricted share units is not subject to payment of a purchase price. The vesting period for the Share Option and Restricted Share Units is four years, and will be allocated in batches by year. The move reflects the company's recognition of employees' past contributions and expectations for their future contributions, and is part of the company's remuneration policy to attract and retain key talent and encourage them to enhance the value of the company and its shares for the overall benefit of the company and its shareholders.
On 28 March 2024, Brii Biosciences Limited granted a total of 5,752,500 shares to 55 licensees under the 2023 Share Option Plan and Share Award Scheme and granted a total of 821,500 restricted shares to 18 restricted share units. The action aims to mobilize employee positivity and align the interests of the company with the welfare of employees. The exercise price of the share option is HK$0.964 per share, and the issuance of restricted share units is not subject to payment of a purchase price. The vesting period for the Share Option and Restricted Share Units is four years, and will be allocated in batches by year. The move reflects the company's recognition of employees' past contributions and expectations for their future contributions, and is part of the company's remuneration policy to attract and retain key talent and encourage them to enhance the value of the company and its shares for the overall benefit of the company and its shareholders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more